Total Neoadjuvant Induction and Consolidation CapeOX Plus IMRT With Capecitabine for MRI Defined High-risk Rectal Cancer
Status:
Completed
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
This study is designed to test the efficacy and safety of total neoadjuvant induction and
consolidation CapeOX plus neoadjuvant intensity modulated radiotherapy with concurrent
capecitabine for MRI defined high-risk rectal cancer.